World journal of clinical oncology

World journal of clinical oncology
中文名称:
世界临床肿瘤学杂志(英文版)
影响因子:
2.6
ISSN:
print: 2218-4333
研究领域:
ONCOLOGY
自引率:
0.00%
Gold OA文章占比:
99.52%
原创研究文献占比:
57.33%
SCI收录类型:
Emerging Sources Citation Index (ESCI)
主办单位:
百世登出版集团有限公司
期刊介绍英文:
The WJCO is a high-quality, peer reviewed, open-access journal. The primary task of WJCO is to rapidly publish high-quality original articles, reviews, editorials, and case reports in the field of oncology. In order to promote productive academic communication, the peer review process for the WJCO is transparent; to this end, all published manuscripts are accompanied by the anonymized reviewers’ comments as well as the authors’ responses. The primary aims of the WJCO are to improve diagnostic, therapeutic and preventive modalities and the skills of clinicians and to guide clinical practice in oncology. Scope: Art of Oncology, Biology of Neoplasia, Breast Cancer, Cancer Prevention and Control, Cancer-Related Complications, Diagnosis in Oncology, Gastrointestinal Cancer, Genetic Testing For Cancer, Gynecologic Cancer, Head and Neck Cancer, Hematologic Malignancy, Lung Cancer, Melanoma, Molecular Oncology, Neurooncology, Palliative and Supportive Care, Pediatric Oncology, Surgical Oncology, Translational Oncology, and Urologic Oncology.
发文信息
发文量:
585
被引量:
2380
中科院SCI期刊分区
2025年3月20日发布
大类 小类 TOP期刊 综述期刊
4区 医学
4区 肿瘤学 ONCOLOGY
WOS期刊分区
学科分类
Q3ONCOLOGY
历年影响因子
2022年2.8000
2023年2.6000
历年发表
2012年25
2013年17
2014年107
2015年46
2016年48
2017年51
2018年25
2019年40
2020年85
2021年91
2022年72
投稿信息
出版周期:
月刊
出版语言:
中文
出版国家(地区):
United States
出版商:
Baishideng Publishing Group
编辑部地址:
北京市

World journal of clinical oncology - 最新文献

Efficacy of disitamab vedotin-containing therapy in metastatic colorectal cancer: A case report.

Pub Date : 2025-03-24 DOI: 10.5306/wjco.v16.i3.99527 Hu-Cheng Yan, Yan Liu, You Feng, Jun-Ming Li, Lei-Ming Sheng, Xin Chen, Yu-Ping Xie, Na Li

Validation of the prognostic model for palliative radiotherapy in older patients with cancer.

Pub Date : 2025-03-24 DOI: 10.5306/wjco.v16.i3.101705 Hyojung Park

Safety and effectiveness of induction chemoimmunotherapy followed by definitive radiotherapy or concurrent chemoradiotherapy in esophageal squamous cell carcinoma.

Pub Date : 2025-03-24 DOI: 10.5306/wjco.v16.i3.101251 Zhuo-Jun Wei, Lin Wang, Rui-Qi Wang, Yu Wang, Huan Chen, Hong-Lian Ma, Yu-Jin Xu
查看全部
免责声明:
本页显示期刊或杂志信息,仅供参考学习,不是任何期刊杂志官网,不涉及出版事务,特此申明。如需出版一切事务需要用户自己向出版商联系核实。若本页展示内容有任何问题,请联系我们,邮箱:info@booksci.cn,我们会认真核实处理。
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信